The Sunday Times's Sabah Meddings told readers to 'hold' shares of Clinigen amid some resurgent 'market chatter' regarding a possible bid emerging for the medicines supplier.
One of Britain's biggest engineering firms is on the cusp of a major break-up after receiving a £2billion takeover approach for its medical division from a US private equity predator. City sources said FTSE 100-listed engineering giant Smiths Group has been holding talks with Boston-based TA Associates. Bankers from Goldman Sachs are said to be working on the deal. - Financial Mail on Sunday.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.